Cancer and COVID-19: Unmasking their ties.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and its clinical manifestation,...
Read More
FDA / Research
Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.
Even though respiratory viruses are one of the most common triggers for asthma exacerbations, not...
Read More
Lancet, NEJM Retract Covid-19 Studies
Studies of RAAS inhibitors, hydroxychloroquine withdrawn for lack of third-party validation In the...
Read More
Some COVID-19 Outpatients Say Famotidine Eased Symptoms
FRIDAY, June 5, 2020 (HealthDay News) — A small number of nonhospitalized patients with...
Read More
Covid-19: Hydroxychloroquine Flops as Postexposure Prophylactic
But last word not yet spoken Hydroxychloroquine is back in the news as another study, just...
Read MoreHype Collides With Science As FDA Tries To Rein In ‘Wild West’ of COVID Blood Tests
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos.
Read More
‘An Arm And A Leg’: The $7,000 COVID Test And Other Lessons From SEASON-19
“An Arm and a Leg” wraps an all-COVID podcast season with three different perspectives on what the pandemic is costing us — and what might come next.
Read More
Hiring A Diverse Army To Track COVID-19 Amid Reopening
Experts estimate local and state health departments will have to hire 100,000 to 300,000 people as contact tracers to get the economy back on track. Many states are trying hard to hire from the racial and ethnic minority communities hit hardest by the virus.
Read More
Rapid Response & Data Sharing During COVID-19 Pandemic
Physicians and healthcare systems across the world have been and continue to respond quickly as...
Read MoreBMI, Tracheal Intubation/Death Linked in Diabetes With COVID-19
In multivariable analyses with covariates, only BMI was positively linked to primary outcome
Read More
Exclusive: Russia, after approving Japanese COVID-19 drug, to roll out ‘game changer’ next week
By Andrew Osborn MOSCOW (Reuters) – Russia will start administering its first approved...
Read More
Co-infections in people with COVID-19: a systematic review and meta-analysis.
In previous influenza pandemics, bacterial co-infections have been a major cause of mortality. We...
Read More
European, South Korean authorities vie for COVID-19 antiviral remdesivir
By Carl O’Donnell and Pushkala Aripaka (Reuters) – European and South Korean...
Read More
Hydroxychloroquine combination risky for cancer patients with COVID-19: study
By Julie Steenhuysen CHICAGO (Reuters) – Cancer patients with COVID-19 who were treated with...
Read More
AstraZeneca picks Oxford Biomedica to make potential COVID-19 vaccine
(Reuters) – AstraZeneca has partnered with British cell therapy company Oxford Biomedica to...
Read More
Indonesia to keep prescribing two malaria drugs for COVID-19 despite bans in Europe
JAKARTA (Reuters) – Indonesia will continue to prescribe two anti-malaria drugs for...
Read More
Covid-19: NIAID Unblinds Remdesivir Trial on Positive, Preliminary Results
Antiviral drug shown superior in lessening time to recovery over placebo Peer-reviewed results...
Read More
Covid-19: WHO Suspends Hydroxychloroquine Arm of Coronavirus Treatment Study
Negative findings from largest study to date prompted the move The World Health Organization has...
Read More
Roche mixes Actemra with Gilead’s remdesivir in COVID-19 trial
ZURICH (Reuters) – Roche plans to test if mixing its anti-inflammation drug Actemra with...
Read More
EU governments ban malaria drug for COVID-19, trial paused as safety fears grow
By Matthias Blamont, Alistair Smout and Emilio Parodi PARIS/LONDON/MILAN (Reuters) –...
Read More